Targeted and immune therapies for cancer have made significant gains for patients but are limited by adaptive and primary resistance.

Cancer cells maintain their fitness by developing survival adaptations that foster escape from intrinsic and extrinsic mechanisms of cell death in conditions of stress.

Larkspur develops first-in-class protein degraders that target key stress-response pathways essential to tumor survival. Degrading these fitness genes unleashes multiple anti-tumor mechanisms to drive cancer cell death.

 

Learn More